Credit: Novartis. The approval was supported by data from phase 3 STEER study, which enrolled patients with SMA who were treatment-naive and able to sit but never able to walk independently. Itvisma ...

Gene therapy delivered for the first time via lumbar puncture showed promise of benefit in slowing progression of giant axonal neuropathy (GAN) in a phase I clinical trial. The slope of change in ...

Please provide your email address to receive an email when new articles are posted on . Patients implanted with a spinal cord simulation system reported less severe pain from baseline to follow up.

Biogen Inc. announced positive interim results from a Phase 1 study of salanersen (BIIB115/ION306), a novel antisense oligonucleotide for treating spinal muscular atrophy (SMA). The data show that ...

Neuropathy, simply defined, is damage to nerves that often results from either disease or trauma. It is a relatively common condition that is not isolated to any particular part of the body. Although ...

Peripheral Neuropathy in its simplest definition is damage to the peripheral nerves — nerves located outside the brain and spinal cord. It is a relatively common condition that is not isolated to any ...